Monoclonal Antibodies in Veterinary Health Market
完整報告名稱與涵蓋範圍
Monoclonal Antibodies in Veterinary Health Market Size, Share & Trends Analysis Report By Type Of Animal (Companion Animals, Livestock), By Application (Dermatology, Pain, Others), By End-User (Veterinary Hospitals, Others), By Region, And By Segment Forecasts, 2025-2034
報告摘要
With a 2024 valuation of USD 0.71 Bn, the global Monoclonal Antibodies in Veterinary Health Market is forecasted to advance to USD 2.98 Bn by 2034, demonstrating a CAGR of 15.7% during the 2025–2034 forecast window.
Monoclonal Antibodies in Veterinary Health encompasses specialized biologic therapies designed to target specific molecules or pathogens in animals to diagnose, prevent, or treat various diseases. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is supported by escalating requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Monoclonal Antibodies Market Snapshot
Chapter 4. Global Monoclonal Antibodies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Monoclonal Antibodies Market Industry Trends
4.10. Global Monoclonal Antibodies Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Monoclonal Antibodies Market Segmentation 1: By Type of Animal, Estimates & Trend Analysis
5.1. Market Share by Type of Animal, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Animal:
5.2.1. Companion Animals
5.2.2. Livestock Animals
Chapter 6. Monoclonal Antibodies Market Segmentation 2: By Application Area, Estimates & Trend Analysis
6.1. Market Share by Application Area, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application Area:
6.2.1. Dermatology
6.2.2. Pain
6.2.3. Other Application Areas
Chapter 7. Monoclonal Antibodies Market Segmentation 4: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Veterinary Hospitals
7.2.2. Other End Users
Chapter 8. Monoclonal Antibodies Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Monoclonal Antibodies Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034
8.2.3. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034
8.2.4. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034
8.3.3. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034
8.3.4. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034
8.4.3. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034
8.4.4. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034
8.5.3. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034
8.5.4. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034
8.6.3. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034
8.6.4. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Boehringer Ingelheim GmbH
9.2.1.1. Business Overview
9.2.1.2. Key Type of Animal/Type of Animal Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence9.2.1.5. Recent Developments with Business Strategy
9.2.2. Elanco
9.2.3. Indian Immunologicals
9.2.4. Merck
9.2.5. Virbac
9.2.6. Zoetis
9.2.7. adivo GmbH (Part of Zoetis),
9.2.8. Bayer Animal Health
9.2.9. Invetx,
9.2.10. Kindred Biosciences, Inc.
9.2.11. Other prominent players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們